New law improves prescription drug access for low-income Ohioans
New law improves prescription drug access for low-income Ohioans
Charitable Pharmacies of America organization member receives Health Equity grant
Healthy People 2030 Leveraging Healthy People to Advance Health Equity Health equity is the attainment of the highest level of health for all people. “Eliminate health disparities, achieve health equity, and attain health literacy to improve the health and well-being of all.”
Around one fourth of the United States population does not have adequate health literacy.
Health literacy is defined as the ability to obtain, read, understand, and apply healthcare
information
Today’s release of new 2020 Census data provides population counts of nearly 1,500 race and ethnicity groups and American Indian and Alaska Native (AIAN) tribes and villages.
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
Want to learn more about Free and Charitable Clinics, Charitable Pharmacies and the medically underserved?
This study represents a rigorous, multi-state evaluation that highlights the impact of a charitable medication access program on hospital utilization for the medically under-served population.
Just as banks have helped seniors bridge the digital divide and leverage online banking to better manage their money, healthcare organizations need to help older adults leverage digital technology to better manage their health.
A Fireside Chat with AAM Chair, Christine Baeder and Mark Cuban, Entrepreneur and Cost Plus founder
FDA approves 1 Year delay of Track & Trace requirements
St. Vincent de Paul Charitable Pharmacy offers article regarding impact of a charitable pharmacy on their community and patients
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2023
Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections

